Cancer diagnostics News and Research

RSS

Tiny medical device containing gold specks could boost effects of cancer drugs

A tiny medical device containing gold specks could boost the effects of cancer medication and reduce its harm, research suggests.

7 Aug 2017

Opioid prescription use found to be more common among cancer survivors

A new study found that opioid prescription use is more common in cancer survivors than in individuals without a history of cancer.

7 Aug 2017

Breast cancer patients treated with targeted radiotherapy experience fewer side effects

Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return, according to trial results published in The Lancet today (Wednesday).

3 Aug 2017

Researchers ferreting out patients most likely to become resistant to cancer treatment

According to the National Cancer Institute, the number of people beating a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024. Now, that's good news, but it doesn't mean that cancer researchers - in the lab or clinic - are resting on any laurels.

2 Aug 2017

Shaping the future of oncology treatment

Victories Over Cancer is about enabling those affected by cancer to enjoy more of life’s meaning full moments and making cancer more manageable. At Janssen, we're really thinking about the elimination of cancer, and we take a very deliberate approach to that.

2 Aug 2017

New law in Rhode Island mandates fertility preservation coverage prior to medical treatment

Rhode Island has become the first state to pass a law explicitly requiring coverage for fertility preservation prior to gonadotoxic medical therapy, treatment that could directly or indirectly cause infertility.

31 Jul 2017

Proscia to showcase digital pathology software, image analysis capabilities at 2017 MedCity CONVERGE

Proscia Inc., a software solutions provider for digital pathology, announced today its CEO David West Jr. will be a featured panelist at 2017 MedCity CONVERGE.

27 Jul 2017

Researchers develop online tool to predict survival of cancer patients

Researchers from the University of Leicester have developed an online tool which presents a variety of measures that quantify the survival of patients with cancer from different perspectives.

26 Jul 2017

Diagnosing prostate cancer through a £225 urine test

This test, which we have branded SelectMDx for Prostate Cancer, came with the acquisition of a company in the Netherlands called NovioGendix. They developed a prototype assay, so they did most of the heavy lifting in terms of discovering the two specific biomarkers that are currently in the product. These biomarkers are tuned towards the detection of what I call clinically significant prostate cancer.

24 Jul 2017

Overweight or obesity in adolescence may increase colon cancer risk in adulthood

A new study has uncovered a link between being overweight or obese in adolescence and an increased risk of developing colon cancer in adulthood. Obesity was also associated with an elevated risk of developing rectal cancer.

24 Jul 2017

New genomic research partnership promises to redefine and transform cancer treatment

Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene Editing Institute of Christiana Care Health System's Helen F. Graham Cancer Center & Research Institute and the biotechnology company NovellusDx.

21 Jul 2017

New technique physically expands tissues to improve breast cancer diagnosis

A Ludwig Cancer Research study offers pathologists a quick, cheap and reliable tool to diagnose diseases such as early breast cancer with a conventional optical microscope.

18 Jul 2017

Proscia introduces new concept to transform pathology labs, drive digital evolution

Proscia Inc., a software solutions provider for digital pathology, announced today the introduction of its new concept: Software as a Lab. Proscia’s President and CEO David West will outline how the pathology lab of the future will operate in a session at the 2017 Digital Pathology Congress: USA on July 10-11 in Chicago.

13 Jul 2017

Cancer diagnosis now more common than marriage, says MacMillan Cancer Support

A new report from MacMillan Cancer Support has revealed that cancer diagnosis is now one of the most common events in people’s lives, with new cases being more common each year in the UK than marriage.

10 Jul 2017

Narrow network insurance plans threaten patient access to treatment choices

Access to high-quality, high-value cancer care is crucial for all patients with cancer. Ideally, following a cancer diagnosis, patients should have the option to choose care from an experienced, multi-disciplinary team of sub-specialists at a comprehensive cancer center that offers the latest cancer treatment and supportive care breakthroughs.

6 Jul 2017

Pre-existing illness delays bowel cancer diagnosis

The researchers from the University of Exeter analysed clinical data from over 4,500 patients across the UK who were later diagnosed with bowel cancer.

5 Jul 2017

New technique to study genetic changes could enhance cancer diagnosis

Large-scale changes to the structure of the genome are often seen in cancer cells. Scientists at the Babraham Institute in Cambridge, UK, have found a way to detect these changes, which could enhance cancer diagnosis and aid the use of targeted treatments.

4 Jul 2017

Scientists use supercomputers to test new techniques for early cancer detection

An important factor in fighting cancer is the speed at which the disease can be identified, diagnosed and treated.

28 Jun 2017

Wyss Institute researchers develop new capture technology for cancer diagnostics

Cancerous tumors are formidable enemies, recruiting blood vessels to aid their voracious growth, damaging nearby tissues, and deploying numerous strategies to evade the body's defense systems.

28 Jun 2017

Study: Postponing lymph node biopsy after melanoma diagnosis does not affect long-term outcomes

Postponing lymph node biopsy more than 30 days after melanoma diagnosis doesn't adversely impact long-term clinical outcomes, according to new study findings published online as an "article in press" on the Journal of the American College of Surgeons website ahead of print publication.

28 Jun 2017

Cancer diagnostics News and Research

Tiny medical device containing gold specks could boost effects of cancer drugs

Opioid prescription use found to be more common among cancer survivors

Breast cancer patients treated with targeted radiotherapy experience fewer side effects

Researchers ferreting out patients most likely to become resistant to cancer treatment

Shaping the future of oncology treatment

New law in Rhode Island mandates fertility preservation coverage prior to medical treatment

Proscia to showcase digital pathology software, image analysis capabilities at 2017 MedCity CONVERGE

Researchers develop online tool to predict survival of cancer patients

Diagnosing prostate cancer through a £225 urine test

Overweight or obesity in adolescence may increase colon cancer risk in adulthood

New genomic research partnership promises to redefine and transform cancer treatment

New technique physically expands tissues to improve breast cancer diagnosis

Proscia introduces new concept to transform pathology labs, drive digital evolution

Cancer diagnosis now more common than marriage, says MacMillan Cancer Support

Narrow network insurance plans threaten patient access to treatment choices

Pre-existing illness delays bowel cancer diagnosis

New technique to study genetic changes could enhance cancer diagnosis

Scientists use supercomputers to test new techniques for early cancer detection

Wyss Institute researchers develop new capture technology for cancer diagnostics

Study: Postponing lymph node biopsy after melanoma diagnosis does not affect long-term outcomes

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News